http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108503645-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63ec19c3f4416dc8297723184302fb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a3eea09f0ed0bc92ce306f081ac778b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5730b1c145be6b3ebcc359b040d9db33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab9071bcd7f6dd9938628fac258a1cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eec2d0b78477dc8b441d26db6033ffe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f1ae3b16345a5a267197067a3fc0e9
publicationDate 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108503645-A
titleOfInvention Aminomethyl-containing piperazinone compound and its preparation method and application
abstract The invention discloses an aminomethyl-containing piperazinone compound, a preparation method and application thereof. Such compounds have the structure shown in general formula (I). The invention also provides the preparation method and application of the compound. The compound of the invention has certain activity of inhibiting AKT1 kinase and growth inhibitory activity of PC‑3 tumor cells, and is used for preparing antitumor drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111646996-A
priorityDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102786482-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465345549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468000630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467994346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467993807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164094225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467023361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163693418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465929908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467359212

Total number of triples: 41.